Hi Bevter - same here, as only a cynical short term hold.
The MTA looks to be a simple transfer of OBJ technology for 3M to play with for their own research - no mention of any trials of note. STI in late 2007 perhaps is an analogy. OBJ's technology is only in the infant academic stage based at Curtin University in Perth with Palermo and cohorts running it for their own ends IMO.
The old octopus, Prof Fraser resigned last year from OBJ.
Dr Quirk is a shared Director of PNO & OBJ and PNO has Pelermo as the Chairman. Edwards, another OBJ Director sold a bundle on market to unsuspecting OBJ retailers on market a fewyears ago - it'll happen again IMO at some point. Quirk sold $120K worth in late 2005 during the pump and Edwards sold close $1m worth on market. Edwards is paid $15,400 per month for OBJ and is listed as being the President, CEO & Director of Molecular Pharmacology on the NASDAQ (Tripeptofen again).
Both companies share the same address. Unfortunately, it all comes down to marketing; the PNO address is the same, but is described as the "Drug Discovery Centre"?? (http://biz.yahoo.com/ic/118/118334.html). Not sure if you've been there.
They've all made a bundle from this type of vehicle - it's quite sad actually but the merry go round still spins.
Add to My Watchlist
What is My Watchlist?